Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Emerging Company Profile

Out of the Arena: With $56M round, spinout Longboard to house trio of neuroscience programs

Emerging Company Profile: Longboard has three programs that each share targets with existing Arena molecules

October 28, 2020 11:25 PM UTC

With $56 million in fresh funding from a crossover syndicate, newly launched Longboard will develop three neuroscience programs spun out from Arena that share familiar targets with therapies previously developed by the parent company.

The syndicate, led by Farallon Capital Management, brings deep-pocketed investors into the fold for a company whose road map includes a potential IPO...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Arena Pharmaceuticals Inc.